Literature DB >> 23443815

Update on treatment strategies for obesity.

Holly R Wyatt1.   

Abstract

Obesity is a disease that is defined as the accumulation of excessive amounts of body fat and is associated with increased risk of serious illness, disability, and death. In clinical practice, obesity is best assessed by calculating body mass index and measuring waist circumference. Treatment options are determined based on the body mass index, waist circumference, and adverse health consequences the patient is experiencing or is at an increased risk for facing in the future. Today, overweight and obesity impacts the majority of patients we treat in our clinical practices. Although endocrinologists are uniquely positioned to treat one of the major consequences of our current obesity epidemic, type 2 diabetes, we also need to be positioned and prepared to effectively treat one of its major causes-obesity. Type 2 diabetes and obesity are very much intertwined. Treatment of each disease affects the other. For these reasons, endocrinologists need to be experts in the treatment of obesity as well as diabetes. They should keep up with advances in obesity treatment including lifestyle, pharmaceutical, and surgical strategies. These strategies offer opportunities for improving the overall treatment for our obese patients today and will continue to improve and expand over the next decade.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23443815      PMCID: PMC3615205          DOI: 10.1210/jc.2012-3115

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  37 in total

1.  Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner.

Authors:  Eduardo G H de Moura; Bruno C Martins; Guilherme S Lopes; Ivan R Orso; Suzana L de Oliveira; Manoel P Galvão Neto; Marco A Santo; Paulo Sakai; Almino C Ramos; Arthur B Garrido Júnior; Marcio C Mancini; Alfredo Halpern; Ivan Cecconello
Journal:  Diabetes Technol Ther       Date:  2011-09-20       Impact factor: 6.118

Review 2.  Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy.

Authors:  Thomas A Wadden; Victoria L Webb; Caroline H Moran; Brooke A Bailer
Journal:  Circulation       Date:  2012-03-06       Impact factor: 29.690

3.  A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial.

Authors:  Meredith C Fidler; Matilde Sanchez; Brian Raether; Neil J Weissman; Steven R Smith; William R Shanahan; Christen M Anderson
Journal:  J Clin Endocrinol Metab       Date:  2011-07-27       Impact factor: 5.958

Review 4.  Naltrexone sustained-release (SR) + bupropion SR combination therapy for the treatment of obesity: 'a new kid on the block'?

Authors:  Niki Katsiki; Apostolos I Hatzitolios; Dimitri P Mikhailidis
Journal:  Ann Med       Date:  2011-01-24       Impact factor: 4.709

5.  Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity.

Authors:  Raj S Padwal; Nicholas M Pajewski; David B Allison; Arya M Sharma
Journal:  CMAJ       Date:  2011-08-15       Impact factor: 8.262

6.  Long-term persistence of hormonal adaptations to weight loss.

Authors:  Priya Sumithran; Luke A Prendergast; Elizabeth Delbridge; Katrina Purcell; Arthur Shulkes; Adamandia Kriketos; Joseph Proietto
Journal:  N Engl J Med       Date:  2011-10-27       Impact factor: 91.245

7.  Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.

Authors:  Katherine M Flegal; Margaret D Carroll; Brian K Kit; Cynthia L Ogden
Journal:  JAMA       Date:  2012-01-17       Impact factor: 56.272

8.  Bariatric surgery: an IDF statement for obese Type 2 diabetes.

Authors:  J B Dixon; P Zimmet; K G Alberti; F Rubino
Journal:  Diabet Med       Date:  2011-06       Impact factor: 4.359

9.  Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study.

Authors:  W Timothy Garvey; Donna H Ryan; Michelle Look; Kishore M Gadde; David B Allison; Craig A Peterson; Michael Schwiers; Wesley W Day; Charles H Bowden
Journal:  Am J Clin Nutr       Date:  2011-12-07       Impact factor: 7.045

10.  Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP).

Authors:  David B Allison; Kishore M Gadde; William Timothy Garvey; Craig A Peterson; Michael L Schwiers; Thomas Najarian; Peter Y Tam; Barbara Troupin; Wesley W Day
Journal:  Obesity (Silver Spring)       Date:  2011-11-03       Impact factor: 5.002

View more
  18 in total

1.  Development and preliminary validity of an Indonesian mobile application for a balanced and sustainable diet for obesity management.

Authors:  Rina Agustina; Eka Febriyanti; Melyarna Putri; Meriza Martineta; Novi S Hardiany; Dyah E Mustikawati; Hanifa Hanifa; Anuraj H Shankar
Journal:  BMC Public Health       Date:  2022-06-20       Impact factor: 4.135

Review 2.  Antiobesity pharmacotherapy for patients with type 2 diabetes: focus on long-term management.

Authors:  Won Seon Jeon; Cheol Young Park
Journal:  Endocrinol Metab (Seoul)       Date:  2014-12-29

3.  Body Mass Index Trajectories among Middle-Aged and Elderly Canadians and Associated Health Outcomes.

Authors:  Meng Wang; Yanqing Yi; Barbara Roebothan; Jennifer Colbourne; Victor Maddalena; Peizhong Peter Wang; Guang Sun
Journal:  J Environ Public Health       Date:  2016-01-27

4.  Effectiveness of a Group Support Lifestyle Modification (GSLiM) Programme among Obese Adults in Workplace: A Randomised Controlled Trial.

Authors:  Siti Noraida Jamal; Foong Ming Moy; Mohd Nahar Azmi Mohamed; Firdaus Mukhtar
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

5.  The Effect of Consumption of Citrus Fruit and Olive Leaf Extract on Lipid Metabolism.

Authors:  Nicola Merola; Julián Castillo; Obdulio Benavente-García; Gaspar Ros; Gema Nieto
Journal:  Nutrients       Date:  2017-09-26       Impact factor: 5.717

6.  Euphorbia kansui Attenuates Insulin Resistance in Obese Human Subjects and High-Fat Diet-Induced Obese Mice.

Authors:  Seung-Wook Lee; Hyun-Young Na; Mi Hyeon Seol; Mia Kim; Byung-Cheol Lee
Journal:  Evid Based Complement Alternat Med       Date:  2017-10-04       Impact factor: 2.629

Review 7.  Deep Brain Stimulation-Possible Treatment Strategy for Pathologically Altered Body Weight?

Authors:  Philip Prinz; Andreas Stengel
Journal:  Brain Sci       Date:  2018-01-22

8.  Preconception consultations with Maternal Fetal Medicine for obese women: a retrospective chart review.

Authors:  Charlotte M Page; Elizabeth S Ginsburg; Randi H Goldman; Chloe A Zera
Journal:  Fertil Res Pract       Date:  2017-01-13

9.  Synergistic Effect of Bupleuri Radix and Scutellariae Radix on Adipogenesis and AMP-Activated Protein Kinase: A Network Pharmacological Approach.

Authors:  Jueun Lee; Jinbong Park; Hyewon Park; Dong-Hyun Youn; Jaehoon Lee; Seokbeom Hong; Jae-Young Um
Journal:  Evid Based Complement Alternat Med       Date:  2018-08-23       Impact factor: 2.629

Review 10.  Management of obesity and cardiometabolic risk - role of phentermine/extended release topiramate.

Authors:  Arianne N Sweeting; Eddy Tabet; Ian D Caterson; Tania P Markovic
Journal:  Diabetes Metab Syndr Obes       Date:  2014-02-12       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.